Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66285-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- OGDH antibody
- Antibody type
- Monoclonal
- Description
- OGDH antibody (Cat. #66285-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1H7A2
- Vial size
- 20ul, 150ul
Submitted references Buyang Huanwu Decoction improves energy metabolism disorders after cerebral ischemia-reperfusion by regulating the SIRT1/AMPK signaling pathway to promote glycolysis and the tricarboxylic acid cycle.
A repurposed AMP binding domain reveals mitochondrial protein AMPylation as a regulator of cellular metabolism.
α-Ketoglutarate promotes cardiomyocyte proliferation and heart regeneration after myocardial infarction.
Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.
Hu Z, Deng N, Li Y, Bai Y, Lan X, Xiong T, Ding H, Liu X, Deng C
Chinese medicine 2025 Jul 7;20(1):108
Chinese medicine 2025 Jul 7;20(1):108
A repurposed AMP binding domain reveals mitochondrial protein AMPylation as a regulator of cellular metabolism.
Gonzalez A, Pon A, Servage K, Pawłowski K, Han Y, Sreelatha A
Nature communications 2025 Aug 23;16(1):7863
Nature communications 2025 Aug 23;16(1):7863
α-Ketoglutarate promotes cardiomyocyte proliferation and heart regeneration after myocardial infarction.
Shi Y, Tian M, Zhao X, Tang L, Wang F, Wu H, Liao Q, Ren H, Fu W, Zheng S, Jose PA, Li L, Zeng C
Nature cardiovascular research 2024 Sep;3(9):1083-1097
Nature cardiovascular research 2024 Sep;3(9):1083-1097
Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
Kumstel S, Schreiber T, Goldstein L, Stenzel J, Lindner T, Joksch M, Zhang X, Wendt EHU, Schönrogge M, Krause B, Vollmar B, Zechner D
PloS one 2022;17(4):e0266601
PloS one 2022;17(4):e0266601
DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.
Leandro J, Dodatko T, Aten J, Nemeria NS, Zhang X, Jordan F, Hendrickson RC, Sanchez R, Yu C, DeVita RJ, Houten SM
Human molecular genetics 2020 May 8;29(7):1168-1179
Human molecular genetics 2020 May 8;29(7):1168-1179
No comments: Submit comment
No validations: Submit validation data